Elevation Oncology Inc (ELEV)
0.58
-0.04
(-6.22%)
USD |
NASDAQ |
Nov 14, 11:54
Elevation Oncology Total Assets (Quarterly): 106.30M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 106.30M |
| June 30, 2024 | 114.60M |
| March 31, 2024 | 108.96M |
| December 31, 2023 | 89.09M |
| September 30, 2023 | 99.98M |
| June 30, 2023 | 110.37M |
| March 31, 2023 | 76.90M |
| December 31, 2022 | 94.16M |
| Date | Value |
|---|---|
| September 30, 2022 | 111.49M |
| June 30, 2022 | 123.78M |
| March 31, 2022 | 134.31M |
| December 31, 2021 | 149.49M |
| September 30, 2021 | 158.52M |
| June 30, 2021 | 159.06M |
| March 31, 2021 | 71.76M |
| December 31, 2020 | 80.91M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
71.76M
Minimum
Mar 2021
159.06M
Maximum
Jun 2021
111.86M
Average
109.67M
Median
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 15.72M |
| IGC Pharma Inc | 10.59M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Protalix BioTherapeutics Inc | 91.54M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 36.95M |
| Shareholders Equity (Quarterly) | 69.36M |